Actively Recruiting
Enteral Feeding of Premature Babies and Olive Oil Supplementation
Led by Bursa City Hospital · Updated on 2024-07-15
80
Participants Needed
1
Research Sites
78 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
It is a two-arm prospective interventional study. 40 babies in both groups will be enrolment in the study. In the intervention group, babies will take 1 ml/kg/day of the study product (ULTRA PREMIUM) after full enteral feeding. Supplementation will continue until discharge or the 36th week. Blood samples will be taken for serum Total antioxidant capacity and Malondialdehyde levels before the intervention and on the 14th day of the control group. At the end of the study, serum will be taken again for control values. Daily lipid intake amounts will be recorded through breast milk analysis. Lipid profile will be monitored weekly The growth parameters of babies will be monitored daily It will be evaluated at the end of the study in terms of ROP, BPD, and NEC. At the end of the study, the data of babies in both groups will be compared.
CONDITIONS
Official Title
Enteral Feeding of Premature Babies and Olive Oil Supplementation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Premature babies born at 32 weeks or less
- Babies who tolerate full enteral feeding before the end of the second week
- Babies given consent by their parents
You will not qualify if you...
- Having a congenital or genetic anomaly
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Bursa City Hospital
Bursa, Turkey (Türkiye), 16110
Actively Recruiting
Research Team
A
Ayten Erdoğan Ordu, MD
CONTACT
M
Murat Tutanc, Prof
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here